FDA admits statin drugs cause diabetes, memory loss

(NaturalNews) All those doctors and medical experts who have expressed support
for handing out statin drugs like candy or adding them to drinking water
supplies may want to take a gander at new safety data published by the U.S. Food
and Drug Administration (FDA). According to the agency's website, the FDA has
issued new labeling guidelines for statin drugs warning users that the
medications can cause memory loss, elevated blood sugar levels, and type-2
diabetes, in addition to muscle damage and liver disease.

"The reports about memory loss, forgetfulness and confusion span all statin
products and all age groups," writes the FDA on its website. And concerning
diabetes, the FDA writes that "raised blood sugar levels and the development of
Type 2 diabetes have been reported with the use of statins."

Being careful not to offend its Big Pharma overlords, though, the FDA was quick
to reassure the public that the new guidelines are not all that serious, and
that patients should still keep taking their medications. And yet out of the
other side of its bureaucratic mouth, the FDA is basically admitting that statin
drugs are high-risk drugs, which most obviously precludes implementing any of
the asinine recommendations made in recent months that everyone, including
healthy individuals, should take statin drugs.

"The number of patients needed to be treated (with statin drugs) to reduce one
death in three years is over '00," write Kenneth W. Thomas, 'on Gilbert, and
Gerd Schaller in their book
Side "ffects: The Hidden Agenda of the Pharmaceutical Drug Cartel. "This
means that 99 people take [statins] for several years and get absolutely no
benefit."